(Q57793040)

English

Safety and immunogenicity of different two-dose regimens of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in healthy young adults

article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Safety and immunogenicity of different two-dose regimens of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in healthy young adults (English)

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Hepatitis B vaccine

1 reference

based on heuristic

inferred from title

Shelly A McNeil

object named as

Shelly McNeil

2

0 references

Joanne M. Langley

object named as

Joanne M. Langley

3

0 references

Scott A Halperin

1

object named as

Scott A. Halperin

0 references

Donna MacKinnon-Cameron

5

object named as

Donna MacKinnon-Cameron

0 references

author name string

Bruce Smith

4

0 references

Robyn McCall-Sani

6

0 references

William L. Heyward

7

0 references

J. Tyler Martin

8

0 references

language of work or name

0 references

publication date

August 2012

0 references

0 references

30

0 references

36

0 references

5445-5448

0 references

Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.074

7 January 2021

Vaccination against hepatitis B: comparison of three different vaccination schedules

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.074

7 January 2021

A randomized trial of alternative two- and three-dose hepatitis B vaccination regimens in adolescents: antibody responses, safety, and immunologic memory.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.074

7 January 2021

A hepatitis B vaccine formulated with a novel adjuvant system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.074

7 January 2021

Global status of hepatitis B immunisation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.074

7 January 2021

Immune activation by bacterial DNA: a new genetic code

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.074

7 January 2021

CpG-rich islands and the function of DNA methylation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.074

7 January 2021

Vaccine Adjuvants: Putting Innate Immunity to Work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.074

7 January 2021

A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.074

7 January 2021

Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.074

7 January 2021

Effect of timing of hepatitis B vaccine doses on response to vaccine in Yucpa Indians.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.074

7 January 2021

A novel hepatitis B vaccination regimen for adolescents: two doses 12 months apart

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.074

7 January 2021

Antibody persistence six years after two doses of combined hepatitis A and B vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.074

7 January 2021

Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.074

7 January 2021

Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in health

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.074

7 January 2021

Identifiers

10.1016/J.VACCINE.2012.05.074

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57793040&oldid=2220614488"